Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue
Collaboration and license revenue	$ 1,049	$ 3,887	$ 2,151	$ 13,838
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Collaboration and license revenue	Collaboration and license revenue	Collaboration and license revenue	Collaboration and license revenue
Operating expenses:
Research and development	$ 26,262	$ 22,741	$ 77,996	$ 65,747
General and administrative	7,409	5,894	22,264	20,192
Total operating expenses	33,671	28,635	100,260	85,939
Loss from operations	(32,622)	(24,748)	(98,109)	(72,101)
Other (expense) income:
Interest and other income, net	3,693	2,733	9,288	5,403
Interest expense	(958)	(982)	(2,869)	(2,907)
Total other income	2,735	1,751	6,419	2,496
Net loss	$ (29,887)	$ (22,997)	$ (91,690)	$ (69,605)
Net loss per share, basic	$ (0.25)	$ (0.24)	$ (0.84)	$ (1.25)
Net loss per share, diluted	$ (0.25)	$ (0.24)	$ (0.84)	$ (1.25)
Weighted average common shares outstanding- basic	118,700,362	94,829,844	109,035,938	55,711,252
Weighted average common shares outstanding-diluted	118,700,362	94,829,844	109,035,938	55,711,252

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.